News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
303 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (266)
2 (303)
3 (319)
4 (449)
5 (141)
6 (5)
7 (8)
8 (327)
9 (447)
10 (392)
11 (296)
12 (287)
13 (12)
14 (10)
15 (364)
16 (243)
17 (199)
18 (254)
19 (138)
20 (3)
21 (22)
22 (199)
23 (184)
24 (146)
25 (10)
26 (23)
27 (1)
28 (31)
29 (202)
30 (252)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
BioMidwest
GEDSA Supports FDA Safety Communication on ENFit® Low Dose Tip Syringe
GEDSA Supports FDA Safety Communication on ENFit ® Low Dose Tip Syringe
November 2, 2021
·
3 min read
Policy
U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection
OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced that the EUA for its InteliSwab™ COVID-19 rapid tests has been amended by the U.S. Food and Drug Administration to only require one test for individuals with symptoms of COVID-19.
November 2, 2021
·
9 min read
Business
Voyager Therapeutics Reports Third Quarter 2021 Financial and Operating Results
Voyager Therapeutics, Inc. today reported third quarter 2021 financial and operating results.
November 2, 2021
·
13 min read
Business
SAGA Diagnostics enters into an assay development agreement with AstraZeneca
SAGA Diagnostics AB has entered into an assay development agreement with the global, science-led biopharmaceutical company AstraZeneca (LSE/STO/Nasdaq: AZN).
November 2, 2021
·
2 min read
Business
Bausch Health Companies Inc. Announces Third-Quarter 2021 Results
Bausch Health Companies Inc. announced its third-quarter 2021 financial results.
November 2, 2021
·
54 min read
Biotech Bay
Antiva Biosciences Closes $31 Million Series D Equity Financing
Antiva Biosciences today announced the closing of a $31 million Series D equity financing.
November 2, 2021
·
5 min read
Business
BrickBio Announces Rapid V2, eCLIC™, Chemistry and Cytokine External Partner Collaboration
BrickBio announced a rapid next-generation conjugation chemistry, eCLIC™
November 2, 2021
·
3 min read
Business
Jnana Therapeutics Announces Promotion of Joel Barrish, Ph.D., to President and Chief Scientific Officer
Jnana Therapeutics today announced the promotion of Joel Barrish, Ph.D., a co-founder of the company, to President and Chief Scientific Officer from his previous role as Chief Scientific Officer.
November 2, 2021
·
3 min read
Cybin Hosting Research and Development Briefing on November 8, 2021
Cybin Inc. will host an in-person and virtual research and development (“R&D”) briefing releasing positive research findings and data on Monday, November 8, 2021 from 8:30 am to 9:30 am (EST)
November 2, 2021
·
6 min read
Business
ADC Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates
ZYNLONTA ® (loncastuximab tesirine-lpyl) third quarter 2021 net sales of $13.1 million
November 2, 2021
·
19 min read
Previous
16 of 31
Next